君实生物的跃迁密码

药智网
Aug 27, 2025

创新药的周期像一条螺旋上升的曲线——政策、资本、技术、需求四股力量时而错位,时而共振。过去几年,行业在估值低谷中完成了一次残酷的供给侧改革:管线同质化公司出清,资金与人才向真正具备“源头创新+国际化”能力的头部企业集中。几年后的今天,当政策端暖风频吹、BD交易金额屡创新高、一级融资回暖、二级股价大涨之时,市场猛然发现,创新药板块已经重新站上风口。这其中,君实生物凭借密集的全球里程碑事件与创新管线...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10